Recent studies have revealed that integrin αxβ2 (CD11c/CD18 and CR4) acts as an effective inducer of early antiviral immunity, controlling viremia during the acute phase of HIV-1 infection through CR4, while integrin αMβ2 (CD11b/CD18 and CR3) downregulates. This evidence concerns the gene ITGB2 and HIV-1 infection.